Promises and failures of gallium as an antibacterial agent
Year: 2016
Type: dissertation
Abstract: The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the\ndisappointingly low discovery rate of new and clinically useful of antibiotics, has focused the\nattention on search for alternatives to conventional antibiotics. Given the crucial role of iron in\nbacterial physiology and pathogenicity, iron metabolism has been evaluated as a possible drug\ntarget. Due to the chemical similarity between gallium and iron, gallium acts as an iron-mimetic\nwhich substitutes for iron in several enzymes, thereby perturbing bacterial metabolism. In the last\nyears, the repurposing of existing (FDA-approved) drugs for new clinical applications has become a\nmajor research area in drug discovery. In this view, the transition metal gallium [Ga(III)], that has a\nlong history as a diagnostic and chemotherapeutic agent, was recently repurposed as an antibacterial\nagent. Gallium has no proven function in biological systems, but acts as an iron-mimetic by\nreplacing iron in redox enzymes, impairing their function and ultimately hampering cell growth. To\ninvestigate the effect of gallium on planktonic and biofilm cells, the Gram-negative bacteria\nPseudomonas aeruginosa and Acinetobacter baumannii were used as model organisms. Both\nspecies represent one of the most frequent cause of hospital-acquired infection (i.e., pneumonia,\nsurgical site infection, urinary tract infection, and bloodstream infection) and are intrinsically\nresistance to many classes of antibiotics. Consequently, the treatment of patients infected with these\npathogens has become very problematic. In the first part of the thesis, the possibility of improving\nthe anti-P. aeruginosa potency of gallium by complex formation with a variety suitable carriers that\nare actively taken up by bacterium, was investigated. It was observed that Ga(III), complexed with\nthe pyochelin siderophore, was more efficient than Ga(NO3)3 in inhibiting P. aeruginosa growth,\nand its activity was dependent on increased Ga(III) entrance into the cell through the pyochelin\ntranslocon.\nSince bacteremia represents a frequent complication of P. aeruginosa infections, it was also\ninvestigated whether Ga(III) would also exert its antibacterial activity in human serum. It was\nobserved that the growth of P. aeruginosa in complement-free human serum depended on the\nability of individual strains to produce proteases that cleave serum proteins, including transferrin,\nultimately causing iron release and stimulation of bacterial growth. In fact, strains displaying high\nproteolytic activity were less susceptible than low proteolytic strains to Ga(NO3)3 in human serum.\nThis phenomenon should be taken into account when assessing the antibacterial efficacy of\nGa(NO3)3, since the ability of bacteria to retrieve iron from the host would counteract growth\ninhibition based on iron mimetism. The high Ga(NO3)3 concentration required to inhibit P.\naeruginosa growth in serum poses a limitation to the potential of Ga(NO3)3 in the treatment of P.\naeruginosa bloodstream infections, and highlights the need for appropriate in vitro condition to\nassess growth inhibition by an iron mimetic.\nThe ability of A. baumannii to adhere and form biofilm on on both biotic and abiotic surface has\nbeen demonstrated and it allows to A. baumannii to survive in the hospital environment for long\ntime. Biofilm-associated infection are very difficult to treat, because the biofilm mode of growth\nreduces antibiotic susceptibility as result of reduced bacterial metabolism. Taken together, these\nobservations prompted us to investigated the anti-biofilm properties of gallium (provided as\ndicitrate salt, Ga-CIT2) against different A. baumannii strains. It was observed that biofilm\nformation was moderately inhibited by Ga-CIT2 while pre-formed biofilms were disrupted by ca.\n50%. Qualitative experiments have shown that Ga-CIT2 was ineffective in disintegrating the biofilm\nmatrix, which is mainly constituted by exopolysaccharides. Interestingly, the Ga-CIT2\nconcentrations required to inhibit and disrupt A. baumannii biofilm were much lower in human\nserum than in iron-poor laboratory medium. Although data obtained in human serum raise new\nhope for gallium treatment of systemic A. baumannii infections, the potential use gallium in coating\nof implants and medical devices should also be considered, given the propensity of A. baumannii to\npersist on biotic and abiotic surfaces. Physiochemical modification of the biomaterial surface to\ncreate anti-adhesive surfaces and incorporation of antimicrobial agents into medical device\npolymers are regarded as the last resort strategy to preserve medical device or surface\ncontaminations that are considered hallmarks of many types of nosocomial infections\nIn the worrisome scenario of expanding drug resistance among Gram-negative bacterial pathogens,\nparticularly A. baumannii and P. aeruginosa, our findings on the antibacterial and antibiofilm\nactivity of gallium could open the way to valuable therapeutic options to cure or prevent otherwise\nuntreatable bacterial infections.
Source: Iris (Roma Tre University)
Author: Bonchi, Carlo
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7033364581
